Objective To assess the measurement accuracy and the utility of the Chinese Abuse Assessment Screen (AAS).Design A cross-sectional study.Setting An antenatal clinic of a public hospital and a community centre in Hong Kong.Sample A total of 257 Chinese women consisting of 100 pregnant women and 157 nonpregnant women.Method The Chinese AAS was administered first, followed by the Chinese Revised Conflict Tactics Scales (CTS2). This was performed in the same sitting, and each participant was interviewed once either at an antenatal clinic (for the pregnant women sample) or at a community centre (for the nonpregnant women sample).Main outcome measures Estimates of the sensitivity, specificity, positive and negative predictive values and positive and negative likelihood ratios.Results Using the Chinese CTS2 as the standard, the specificity estimates of the Chinese AAS for emotional, physical and sexual abuse were ‡89%, while the sensitivity estimates varied from 36.3 to 65.8%. The sensitivity improved in the screening for more severe cases (66.7%). The positive predictive values were ‡80%, and the negative predictive values varied from 66 to 93%. Factors such as the age difference between the couple and the woman's need for financial assistance were found to be associated with intimate partner violence (IPV). ConclusionThe Chinese AAS has demonstrated satisfactory measurement accuracy and utility for identifying IPV when the Chinese CTS2 was used as the standard.
We report a boy with relapse of diabetes after 82 months (6.8 years). This boy was hospitalized with severe DϩHUS when he was 6 years old. During his stay in the intensive care unit, he developed hyperglycemia and was treated with insulin during 21 days. Eighty months later he presented with nose obstruction and headache and was diagnosed with sinusitis and polyposis nasi. He was treated with antibiotics, but the complaints persisted. Two months later, he was operated on (functional endoscopic sinus surgery), and postoperatively he received 2 mg betamethason for 5 days. On the 5th day, he presented in the emergency department with polyuria, polydipsia, and lethargy. His glycemia was 1,500 mg/dl, and his blood pH was 7.33. He was intravenously treated with insulin, and the corticosteroids were ceased.To differentiate between type 1 diabetes, glucocorticoid-induced diabetes, and post-HUS diabetes, some additional blood tests were done. Pancreatic autoantibodies, including islet cell, insulin, GAD65, and insulinoma-associated protein 2 antibodies were all negative. Insulin was 4 mU/l for a glycemia of 1,453 mg/dl. After normalization of the glycemia, the boy was started on a basal-bolus regimen with insulin aspart and insulin glargine. Twenty months later, he still requires insulin (0.5 units ⅐ kg Ϫ1 ⅐ day Ϫ1 ) and has an HbA 1c of 6.8%.Our report in which we describe a relapse of diabetes after 82 months confirms the conclusion of Suri et al. that survivors of DϩHUS should have aggressive surveillance and treatment of hyperglycemia, not only in the acute phase but also in the long run.
Non-invasive ultrasound parameters, in particular quantification of intrahepatic umbilical venous maximum flow velocity and middle cerebral artery peak flow velocity, were found to be useful in the diagnosis and management of fetal anemia in pregnancies with fetal homozygous alpha-thalassemia-1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.